Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1978-11-30
1981-02-10
Robinson, Allen J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424127, 424236, 424266, 424267, 424274, 424317, 424319, 424329, 424337, A61K 3119, A61K 31195, A61K 31235, A61K 31455
Patent
active
042501911
ABSTRACT:
A method and substances are featured for reducing the risk of incurring renal damage or failure. Substances useful in the treatment of hyperlipidemia and closely-related vascular conditions have been found to reduce or prevent renal failure. The substances most generally utilized are derivatives of phenoxyacetic acid. These substances are administered from 0.01 to 0.25% by weight of the dietary materials ingested by the host which is equivalent to 0.2 to 6.0 grams per day in man.
REFERENCES:
patent: 3262850 (1966-07-01), Jones et al.
patent: 3517050 (1970-06-01), Bolhofer
Schapel et al.; In Drugs & The Kidney, Edwards, K. D. G., _Ed. Progr. Biochem, Pharmacol., vol. 9, pp. 82-98, Karger, Basel 1974.
Edwards; In Drugs Affecting Kidney Function & Metabolism, _Edwards, K. D. G., Ed. Progr. Biochem. Pharmacol., vol. 7, pp. 370-426, Karger, Basel 1972.
Schapel et al., J. Pharmacol. Exper. ther. 194:274-284, (1975).
Edwards, Artery 3(2):135-149, Apr. 1977.
Med. Journal of Australia, 2:115-118, 1974.
LandOfFree
Preventing renal failure does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preventing renal failure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preventing renal failure will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1665588